Michael Skynner
Technik-/Wissenschafts-/F&E-Leiter bei BICYCLE THERAPEUTICS PLC
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von Michael Skynner
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BICYCLE THERAPEUTICS PLC | Technik-/Wissenschafts-/F&E-Leiter | 03.01.2022 | - |
Geschäftsführer | 01.01.2018 | 03.01.2022 | |
Bicycle Therapeutics, Inc.
Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bicycle Therapeutics Plc, Bicycle Therapeutics, Inc. develops medicines and therapeutics for cancer treatment. The company is based in Lexington, MA. The company was founded in 2009 by Kevin Lee. Kevin Lee has been the CEO since 2009. | Geschäftsführer | 01.01.2018 | - |
Karriereverlauf von Michael Skynner
Ehemalige bekannte Positionen von Michael Skynner
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PFIZER, INC. | Corporate Officer/Principal | 01.09.2013 | 01.01.2016 |
Cambridge Biotechnology Ltd.
Cambridge Biotechnology Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Biotechnology Ltd. is a wholly owned subsidiary of Biovitrum AB. The company's founders originate from a Pfizer Global Research & Development drug discovery team in what had previously been the Parke-Davis Neuroscience Research Centre. The founders, together with some key academic collaborators, created the company to exploit several opportunities in drug discovery as well as their world class 'gene to lead' drug discovery capability. The company has well equipped modern laboratory and office facilities situated on the Babraham Research Campus. This location allows the company to forge links with a host of world class research groups based in the Cambridge area. CBT is always looking to identify potential partner companies for both in-licensing and risk-sharing drug discovery ventures. | Gründer | 01.05.2001 | 01.05.2005 |
Ausbildung von Michael Skynner
Imperial College London | Doctorate Degree |
Statistik
International
Vereinigtes Königreich | 4 |
Vereinigte Staaten | 3 |
Operativ
Chief Operating Officer | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 4 |
Commercial Services | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BICYCLE THERAPEUTICS PLC | Health Technology |
PFIZER, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Cambridge Biotechnology Ltd.
Cambridge Biotechnology Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Biotechnology Ltd. is a wholly owned subsidiary of Biovitrum AB. The company's founders originate from a Pfizer Global Research & Development drug discovery team in what had previously been the Parke-Davis Neuroscience Research Centre. The founders, together with some key academic collaborators, created the company to exploit several opportunities in drug discovery as well as their world class 'gene to lead' drug discovery capability. The company has well equipped modern laboratory and office facilities situated on the Babraham Research Campus. This location allows the company to forge links with a host of world class research groups based in the Cambridge area. CBT is always looking to identify potential partner companies for both in-licensing and risk-sharing drug discovery ventures. | Commercial Services |
Bicycle Therapeutics, Inc.
Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bicycle Therapeutics Plc, Bicycle Therapeutics, Inc. develops medicines and therapeutics for cancer treatment. The company is based in Lexington, MA. The company was founded in 2009 by Kevin Lee. Kevin Lee has been the CEO since 2009. | Health Technology |
- Börse
- Insiders
- Michael Skynner
- Erfahrung